Polio Sabin

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, RotavirusInfections, Streptococcal

Phase 2

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

CompletedNCT00263666

GlaxoSmithKlineInfections, Rotavirus

Start: 2005-03-16End: 2008-02-13Updated: 2020-11-23

Phase 3

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

CompletedNCT00547248

GlaxoSmithKlineInfections, Streptococcal

Start: 2007-10-22End: 2008-10-07Updated: 2019-01-14

Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

CompletedNCT01175083

GlaxoSmithKlineInfections, Streptococcal

Start: 2011-06-01End: 2013-05-23Updated: 2019-06-06

Related Papers

Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.

2017-05-013 citations